These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7423596)
21. Freezing red blood cells prepared for quality control of antiglobulin sera. Szymanski IO; Harper JM; Odgren PR; Valeri CR Transfusion; 1981; 21(5):498-501. PubMed ID: 6794193 [TBL] [Abstract][Full Text] [Related]
22. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1. Medof ME; Nussenzweig V J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387 [TBL] [Abstract][Full Text] [Related]
23. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway. Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629 [TBL] [Abstract][Full Text] [Related]
24. A simple method for high-quality frozen red cells in blood group serology. Högman CF; Hornblower ML; Flodin M; Gillberg G; Meryman HT; Säfwenberg J Transfusion; 1986; 26(5):434-6. PubMed ID: 3765037 [TBL] [Abstract][Full Text] [Related]
25. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man. Atkinson JP; Frank MM J Clin Invest; 1974 Aug; 54(2):339-48. PubMed ID: 4847248 [TBL] [Abstract][Full Text] [Related]
26. The significance of complement in immunohematology. Garratty G Crit Rev Clin Lab Sci; 1984; 20(1):25-56. PubMed ID: 6373144 [TBL] [Abstract][Full Text] [Related]
27. GLYCEROL TREATED HUMAN RED CELLS FROZEN WITH LIQUID NITROGEN. KRIJNEN HW; DE WIT JJ; KUIVENHOVEN AC; LOOS JA; PRINS HK Vox Sang; 1964; 9():559-72. PubMed ID: 14221593 [No Abstract] [Full Text] [Related]
28. The rapid identification of Chido and Rodgers antibodies using C4d-coated red blood cells. Judd WJ; Kraemer K; Moulds JJ Transfusion; 1981; 21(2):189-92. PubMed ID: 7222201 [TBL] [Abstract][Full Text] [Related]
29. Reproducible in vitro preparation of intermediate C3d coated red blood cells. Hoffman NL; Monroe MC; Chaplin H Transfusion; 1982; 22(3):180-4. PubMed ID: 7046159 [TBL] [Abstract][Full Text] [Related]
30. The role of macromolecular components in anti-gamma, alpha, mu, kappa, lambda, C3 and C4 antiglobulin sera. Haynes CR; Chaplin H Br J Haematol; 1971 Sep; 21(3):277-87. PubMed ID: 4998791 [No Abstract] [Full Text] [Related]
31. The fourth component of human complement treated with amines or chaotropes or frozen-thawed (C4b-like C4): interaction with C4 binding protein and cleavage by C3b/C4b inactivator. von Zabern I; Bloom EL; Chu V; Gigli I J Immunol; 1982 Mar; 128(3):1433-8. PubMed ID: 6976993 [TBL] [Abstract][Full Text] [Related]
32. Liquid nitrogen preservation of red blood cells for transfusion; a low glycerol-rapid freeze procedure. Rowe AW; Eyster E; Kellner A Cryobiology; 1968; 5(2):119-28. PubMed ID: 5717951 [No Abstract] [Full Text] [Related]
34. Studies on the preservation of red blood cells. Attachment of the third component of human complement to erythrocytes during storage at 4 degrees C. Szymanski IO; Odgren PR Vox Sang; 1979; 36(4):213-24. PubMed ID: 462911 [TBL] [Abstract][Full Text] [Related]
35. Complement-coated antibody-transfer (CCAT); serum IgA1 antibodies intercept and transport C4 and C3 fragments and preserve IgG1 deployment (PGD). Boackle RJ; Nguyen QL; Leite RS; Yang X; Vesely J Mol Immunol; 2006 Feb; 43(3):236-45. PubMed ID: 16199260 [TBL] [Abstract][Full Text] [Related]
36. A method for freezing and washing red blood cells using a high glycerol concentration. Meryman HT; Hornblower M Transfusion; 1972; 12(3):145-56. PubMed ID: 5026166 [No Abstract] [Full Text] [Related]
37. Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes. Kinoshita T; Medof ME; Nussenzweig V J Immunol; 1986 May; 136(9):3390-5. PubMed ID: 2420889 [TBL] [Abstract][Full Text] [Related]
38. Current methods for processing frozen red cells. Valeri CR; Brodine CE Cryobiology; 1968; 5(2):129-35. PubMed ID: 4975814 [No Abstract] [Full Text] [Related]
39. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. Medof ME; Kinoshita T; Nussenzweig V J Exp Med; 1984 Nov; 160(5):1558-78. PubMed ID: 6238120 [TBL] [Abstract][Full Text] [Related]
40. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Gigli I; Fujita T; Nussenzweig V Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6596-600. PubMed ID: 293746 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]